- Home
- ESEA vs YDES Comparison
ESEA vs YDES Comparison
Compare ESEA & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESEA | YDES |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | Greece | Taiwan |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 484.0M | 543.0M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESEA | YDES |
|---|---|---|
| Price | $70.21 | $2.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $62.00 | N/A |
| AVG Volume (30 Days) | 52.5K | ★ 336.1K |
| Earning Date | 06-17-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.74 | N/A |
| Revenue Next Year | $1.07 | N/A |
| P/E Ratio | $3.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.51 | $1.70 |
| 52 Week High | $78.76 | $25.00 |
Technical Indicators
Market Signals| Indicator | ESEA | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 37.61 |
| Support Level | $63.64 | $1.92 |
| Resistance Level | $72.24 | $5.36 |
| Average True Range (ATR) | 2.46 | 0.51 |
| MACD | 0.28 | 0.04 |
| Stochastic Oscillator | 88.48 | 26.59 |
Price Performance
Historical ComparisonAbout ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.